Mao C, You W, Yang Y, Cheng H, Hu X, Lan X
J Anim Sci Biotechnol. 2025; 16(1):36.
PMID: 40045371
PMC: 11884139.
DOI: 10.1186/s40104-025-01164-2.
Su N, Yu X, Duan M, Shi N
Genes Dis. 2024; 12(1):101201.
PMID: 39524539
PMC: 11550756.
DOI: 10.1016/j.gendis.2023.101201.
Liu J, Zhang X, Xu W, Hao X
Front Immunol. 2024; 15:1439485.
PMID: 39229278
PMC: 11368726.
DOI: 10.3389/fimmu.2024.1439485.
Gao G, Hao Y, Wang C, Gao P
Front Pharmacol. 2024; 15:1360607.
PMID: 39108751
PMC: 11300364.
DOI: 10.3389/fphar.2024.1360607.
Wang Y, Yang C, Sun H, Jiang H, Zhang P, Huang Y
Genomics Proteomics Bioinformatics. 2024; 22(4).
PMID: 38937660
PMC: 11514847.
DOI: 10.1093/gpbjnl/qzae050.
Exploring the enigma: history, present, and future of long non-coding RNAs in cancer.
Naseer Q, Malik A, Zhang F, Chen S
Discov Oncol. 2024; 15(1):214.
PMID: 38847897
PMC: 11161455.
DOI: 10.1007/s12672-024-01077-y.
VIRMA promotes the progression of head and neck squamous cell carcinoma by regulating mRNA and m6A levels.
Zhu C, Cheng Y, Yu Y, Zhang Y, Ren G
Biomol Biomed. 2024; 24(5):1244-1257.
PMID: 38577917
PMC: 11379021.
DOI: 10.17305/bb.2024.10358.
N-methylation in the development, diagnosis, and treatment of gastric cancer.
Wang J, Zhao G, Zhao Y, Zhao Z, Yang S, Zhou A
J Transl Int Med. 2024; 12(1):5-21.
PMID: 38525439
PMC: 10956730.
DOI: 10.2478/jtim-2023-0103.
Therapeutic effect and transcriptome-methylome characteristics of METTL3 inhibition in liver hepatocellular carcinoma.
Liu Q, Qi J, Li W, Tian X, Zhang J, Liu F
Cancer Cell Int. 2023; 23(1):298.
PMID: 38012755
PMC: 10683134.
DOI: 10.1186/s12935-023-03096-1.
Catalytic activity of the Bin3/MePCE methyltransferase domain is dispensable for 7SK snRNP function in Drosophila melanogaster.
Palumbo R, Yang Y, Feigon J, Hanes S
Genetics. 2023; 226(1).
PMID: 37982586
PMC: 10763541.
DOI: 10.1093/genetics/iyad203.
N6-methyladenosine methylation in kidney injury.
Wang Q, Fan X, Sheng Q, Yang M, Zhou P, Lu S
Clin Epigenetics. 2023; 15(1):170.
PMID: 37865763
PMC: 10590532.
DOI: 10.1186/s13148-023-01586-7.
Decoding mA mRNA methylation by reader proteins in liver diseases.
Sun L, Chen X, Zhu S, Wang J, Diao S, Liu J
Genes Dis. 2023; 11(2):711-726.
PMID: 37692496
PMC: 10491919.
DOI: 10.1016/j.gendis.2023.02.054.
Dysregulation and implications of N6-methyladenosine modification in renal cell carcinoma.
Wu Y, Zhang S, Chen C, Pang J
Curr Urol. 2023; 17(1):45-51.
PMID: 37692138
PMC: 10487297.
DOI: 10.1097/CU9.0000000000000135.
The yeast RNA methylation complex consists of conserved yet reconfigured components with m6A-dependent and independent roles.
Ensinck I, Maman A, Albihlal W, Lassandro M, Salzano G, Sideri T
Elife. 2023; 12.
PMID: 37490041
PMC: 10393049.
DOI: 10.7554/eLife.87860.
The Regulation of m6A Modification in Glioblastoma: Functional Mechanisms and Therapeutic Approaches.
Deacon S, Walker L, Radhi M, Smith S
Cancers (Basel). 2023; 15(13).
PMID: 37444417
PMC: 10340774.
DOI: 10.3390/cancers15133307.
Crosstalk between m6A and coding/non-coding RNA in cancer and detection methods of m6A modification residues.
Meng Q, Schatten H, Zhou Q, Chen J
Aging (Albany NY). 2023; 15(13):6577-6619.
PMID: 37437245
PMC: 10373953.
DOI: 10.18632/aging.204836.
The role of mA demethylase FTO in chemotherapy resistance mediating acute myeloid leukemia relapse.
Zhang Z, Zhao X, Guo H, Huang X
Cell Death Discov. 2023; 9(1):225.
PMID: 37402730
PMC: 10319875.
DOI: 10.1038/s41420-023-01505-y.
Targeting IGF2BP3 in Cancer.
Liu X, Chen J, Chen W, Xu Y, Shen Y, Xu X
Int J Mol Sci. 2023; 24(11).
PMID: 37298373
PMC: 10253605.
DOI: 10.3390/ijms24119423.
N6-methyladenosine (m6A) as a regulator of carcinogenesis and drug resistance by targeting epithelial-mesenchymal transition and cancer stem cells.
Wang C, Ma D, Yu H, Zhuo Z, Ye Z
Heliyon. 2023; 9(3):e14001.
PMID: 36915498
PMC: 10006539.
DOI: 10.1016/j.heliyon.2023.e14001.
Opposing regulation of the Nα-trimethylase METTL11A by its family members METTL11B and METTL13.
Parker H, Schaner Tooley C
J Biol Chem. 2023; 299(4):104588.
PMID: 36889590
PMC: 10166787.
DOI: 10.1016/j.jbc.2023.104588.